Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polar Investments is an Israeli-based holding and investment company that has historically maintained a significant presence in the life sciences, biotechnology, and technology sectors. The company operates by taking controlling or significant minority positions in a diverse portfolio of public and private entities, providing strategic guidance and capital to accelerate growth. In the healthcare space, it has been notably involved with innovative Israeli firms such as Compugen and NasVax, focusing on biopharmaceutical development and medical technologies. While its broader business interests include real estate and communications, its role as a venture-style investor has made it a key player in the Israeli biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polar Investments.